Cellular co-localization of phosphorylated tau- and NACP/α-synuclein- epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

Brain Research

Volumn 843, Issue 1-2, 1999, Pages 53-61

  Arima, Kunimasa ^a,b   Hirai, Shigeo ^b   Sunohara, Nobuhiko ^b,c   Aoto, Kazuko ^c   Izumiyama, Yoko ^a   Uéda, Kenji ^a   Ikeda, Kazuhiko ^a   Kawai, Mitsuru ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b National Center of Neurology and Psychiatry   (Japan)

^c Hakone National Hospital   (Japan)

Author keywords

Filament aggregation; Lewy body; NACP; Neuronal degeneration; Synuclein; Tau

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; EPITOPE; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; EPITOPES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PHOSPHOPROTEINS; PHOSPHORYLATION; SYNUCLEINS; TAU PROTEINS;

EID: 0032849237     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01848-X     Document Type: Article

References (32)

1. Arima K., Nakamura M., Sunohara N., Ogawa M., Anno M., Izumiyama Y., Hirai S., Ikeda K. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol. 93:1997;558-566.
2. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 96:1998;439-444.
3. K. Arima, K. Uéda, N. Sunohara, S. Hirai, Y. Izumiyama, H. Tonozuka-Uehara, M. Kawai, Immunoelectron-microscopic demonstration of NACP/α-synuclein epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies, Brain Res. (1998) 93-100.
4. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lwey bodies. Am. J. Pathol. 152:1998;879-884.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
6. Brion J.P., Couck A.M. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am. J. Pathol. 147:1995;1465-1476.
7. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson's disease. Nature Medicine. 4:1998;1318-1320.
8. El-Agnaf O.M.A., Jakes R., Curran M.D., Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440:1998;67-70.
9. Fearnley J.M., Revesz T., Brooks D.J., Frackowiak R.S.J., Lees A.J. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J. Neurol. Neurosurg. Psychiatr. 54:1991;159-161.
10. Galloway P.G., Grundke-Iqebal I., Iqbal K., Perry G. Lewy body contain epitopes both shared and distinct from Alzheimer neurofibrillary taggles. Neurosci. Lett. 47:1988;654-663.
11. Goedert M., Jakes R., Crowther R.A., Six J., Lübke U., Vandermeeren M., Cras P., Trojanowski J.Q., Lee V.M.-Y. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer's disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5066-5070.
12. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 383:1996;550-553.
13. Grundke-Iqebal I., Iqbal K., Quinlan M., Tung Y., Zaidi M.S., Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261:1986;6084-6089.
14. Grundke-Iqebal I., Iqbal K., Tung Y., Quinlan M., Wisniewski H.M., Binder L. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4913-4917.
15. Hardy J., Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 282:1998;1075-1079.
16. Harrington C.R., Perry R.H., Perry E.K., Hurt J., McKeith I.G., Roth M., Wischik C.M. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia. 5:1994;215-228.
17. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
18. Jakes R., Spillantini M.G., Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 345:1994;27-32.
19. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genetics. 18:1998;106-108.
20. Lippa C.F., Fujiwara H., Mann D.M.A., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., George-Hyslop P.St., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M.Y., Iwatsubo T., Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153:1998;1365-1370.
21. McKeith L.G., Galasko D., Kosaka K., Perry E.K., Dickson D., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
22. P. Monaghan, D. Robertson, Immunolabelling techniques for electron microscopy, in: J.E. Beesley (Ed.), Immunocytochemistry, a Practical Approach, Oxford Univ. Press, Oxford, 1993, pp. 43-76.
23. Pei J.J., Grundke-Iqebal I., Iqubal K., Bogdanovic N., Winblad B., Cowburn R.F. Accumulation of cyclin-dempendent kinase 5 in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797:1998;267-277.
24. Pollanen M.S., Bergeron C., Weyer L. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments. Acta Neuropathol. 88:1994;1-6.
25. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:1993;183-191.
26. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
27. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6469-6473.
28. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends in Neurosciences. 21:1998;428-433.
29. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
30. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am. J. Pathol. 152:1998;367-372.
31. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11282-11286.
32. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239:1997;45-48.